First-pass extracted concept

CRISPR-Cas

Candidate: concept label3 source documents5 linked claims
Live refresh every 5sNext refresh in 5s

Evidence Snippets

they offer a promising alternative to protein-based systems such as TetON/OFF or CRISPR-Cas.
Evidence 1Source 1DOIPubMedprovenance
The field has evolved from protein-based systems (e.g., zinc finger nucleases and transcription activator-like effector nucleases) to RNA-guided systems (e.g., CRISPR-Cas) that can control both genetic and epigenetic states.
Evidence 2Source 2DOIPubMedprovenance
PubMed indexes the editorial with the keyword 'crispr cas', and the source PDF notes FungalBraid toolkit support for CRISPR/Cas systems.
Evidence 3Source 3DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1comparative advantagesupports2025Source 1DOIPubMed

Synthetic riboswitches offer a promising alternative to protein-based systems such as TetON/OFF or CRISPR-Cas.

Claim 2functional capabilitysupports2025Source 2DOIPubMed

CRISPR-Cas is described here as able to control both genetic and epigenetic states.

Quoted textsource-backed
RNA-guided systems (e.g., CRISPR-Cas) that can control both genetic and epigenetic states.
Claim 3technology evolutionsupports2025Source 2DOIPubMed

The field is described as having evolved from protein-based systems such as zinc finger nucleases and TALENs to RNA-guided systems such as CRISPR-Cas.

Quoted textsource-backed
The field has evolved from protein-based systems (e.g., zinc finger nucleases and transcription activator-like effector nucleases) to RNA-guided systems (e.g., CRISPR-Cas)
Claim 4tool descriptionsupports2024Source 3DOIPubMed

The source explicitly mentions FungalBraid as a GoldenBraid-compatible modular cloning platform for filamentous fungi with CRISPR/Cas support.

Claim 5topic scopesupports2024Source 3DOIPubMed

This editorial covers recent advances in applying synthetic biology to production of bioactive compounds.